Nicolas Véziris

6.8k total citations
139 papers, 3.5k citations indexed

About

Nicolas Véziris is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Nicolas Véziris has authored 139 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Infectious Diseases, 109 papers in Epidemiology and 53 papers in Surgery. Recurrent topics in Nicolas Véziris's work include Tuberculosis Research and Epidemiology (115 papers), Mycobacterium research and diagnosis (87 papers) and Infectious Diseases and Tuberculosis (42 papers). Nicolas Véziris is often cited by papers focused on Tuberculosis Research and Epidemiology (115 papers), Mycobacterium research and diagnosis (87 papers) and Infectious Diseases and Tuberculosis (42 papers). Nicolas Véziris collaborates with scholars based in France, Morocco and United States. Nicolas Véziris's co-authors include Vincent Jarlier, Florence Brossier, C. Truffot-Pernot, Alexandra Aubry, Wladimir Sougakoff, Emmanuelle Cambau, Nacer Lounis, Aurélie Chauffour, Koen Andries and Jean‐Louis Gaillard and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Nicolas Véziris

130 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Véziris France 32 2.7k 2.7k 784 760 543 139 3.5k
Beverly Metchock United States 28 3.0k 1.1× 2.6k 1.0× 589 0.8× 1.3k 1.7× 125 0.2× 53 3.7k
Thomas Schön Sweden 30 2.2k 0.8× 1.7k 0.6× 446 0.6× 611 0.8× 137 0.3× 121 2.9k
Linda M. Parsons United States 29 3.0k 1.1× 2.7k 1.0× 905 1.2× 1.2k 1.6× 125 0.2× 57 4.6k
Doris Hillemann Germany 32 3.9k 1.4× 3.5k 1.3× 1.0k 1.3× 1.9k 2.5× 184 0.3× 87 5.0k
Leen Rigouts Belgium 37 3.7k 1.4× 3.5k 1.3× 717 0.9× 1.6k 2.0× 219 0.4× 172 4.3k
Sven Hoffner Sweden 32 2.7k 1.0× 2.4k 0.9× 556 0.7× 1.0k 1.3× 103 0.2× 81 3.0k
C. Truffot-Pernot France 34 3.9k 1.4× 3.4k 1.3× 1.7k 2.1× 1.1k 1.4× 284 0.5× 96 5.1k
Vishwa Mohan Katoch India 31 2.1k 0.8× 1.7k 0.7× 676 0.9× 737 1.0× 140 0.3× 94 2.8k
Ákos Somoskövi United States 24 1.9k 0.7× 1.9k 0.7× 301 0.4× 763 1.0× 269 0.5× 68 2.5k
C N Paramasivan India 32 2.5k 0.9× 2.1k 0.8× 507 0.6× 1.1k 1.4× 127 0.2× 96 3.2k

Countries citing papers authored by Nicolas Véziris

Since Specialization
Citations

This map shows the geographic impact of Nicolas Véziris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Véziris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Véziris more than expected).

Fields of papers citing papers by Nicolas Véziris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Véziris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Véziris. The network helps show where Nicolas Véziris may publish in the future.

Co-authorship network of co-authors of Nicolas Véziris

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Véziris. A scholar is included among the top collaborators of Nicolas Véziris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Véziris. Nicolas Véziris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnet, Isabelle, Mickael Orgeur, Florence Brossier, et al.. (2025). Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148. Microbiology Spectrum. 13(7). e0322424–e0322424. 1 indexed citations
2.
Monsel, Gentiane, Vincent Dubée, Patricia Pavèse, et al.. (2025). Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 Patients. Open Forum Infectious Diseases. 12(8). ofaf450–ofaf450. 1 indexed citations
3.
Verma, Amit Kumar, Robbert Q. Kim, Dirk A. Lamprecht, et al.. (2025). Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3. PubMed. 2(1). 6–6.
4.
Maitre, Thomas, et al.. (2024). Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis. Antimicrobial Agents and Chemotherapy. 68(11). e0058324–e0058324.
5.
Loebinger, Michael R., Stefano Aliberti, Charles Haworth, et al.. (2024). Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts. ERJ Open Research. 10(5). 791–2023. 1 indexed citations
6.
Aliberti, Stefano, Francesco Blasi, Pierre‐Régis Burgel, et al.. (2024). Mycobacterium aviumcomplex pulmonary disease patients with limited treatment options. ERJ Open Research. 10(1). 610–2023. 2 indexed citations
7.
Rouzaud, Claire, Sylvain Bodard, Emmanuelle Bille, et al.. (2024). Successful rescue TNF-α blocking for Mycobacterium genavense – Related immune reconstitution inflammatory syndrome: A case report. Heliyon. 10(7). e29341–e29341.
8.
Chauffour, Aurélie, Nacer Lounis, Koen Andries, et al.. (2023). Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy. PLoS neglected tropical diseases. 17(11). e0011379–e0011379. 5 indexed citations
9.
Andréjak, Claire, Emmanuel Beillard, Geneviève Guillot, et al.. (2022). Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008–2018. PLoS neglected tropical diseases. 16(9). e0010693–e0010693. 5 indexed citations
10.
Véziris, Nicolas, Claire Andréjak, S. Bouée, et al.. (2021). Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study. BMC Infectious Diseases. 21(1). 1165–1165. 8 indexed citations
11.
Jaspard, Marie, Najoua El Helali, Dhiba Marigot-Outtandy, et al.. (2020). Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France. Emerging infectious diseases. 26(8). 1792–1800. 38 indexed citations
12.
Maitre, Thomas, Aurélie Chauffour, Christine Bernard, et al.. (2017). Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?. Journal of Antimicrobial Chemotherapy. 72(8). 2326–2333. 25 indexed citations
13.
Mougari, Faïza, Rishma Amarsy, Nicolas Véziris, et al.. (2016). Standardized interpretation of antibiotic susceptibility testing and resistance genotyping forMycobacterium abscessuswith regard to subspecies anderm41sequevar. Journal of Antimicrobial Chemotherapy. 71(8). 2208–2212. 49 indexed citations
14.
Catho, Gaud, S. Couraud, S. Grard, et al.. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection. 21(5). 472.e7–472.e10. 4 indexed citations
15.
Roux, Anne‐Laure, Émilie Catherinot, Nathalie Soismier, et al.. (2014). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis. 14(1). 63–69. 69 indexed citations
16.
Bastian, Sylvaine, Nicolas Véziris, Anne‐Laure Roux, et al.. (2010). Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl Sequencing. Antimicrobial Agents and Chemotherapy. 55(2). 775–781. 269 indexed citations
17.
Truffot-Pernot, C., et al.. (2009). Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(6). 553–557. 61 indexed citations
18.
Véziris, Nicolas. (2008). Early and Late Bactericidal Activity of R207910 (TMC207) in Murine Tuberculosis. 46th Annual Meeting. 1 indexed citations
19.
20.
Véziris, Nicolas, Nacer Lounis, Aurélie Chauffour, et al.. (2008). A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 179(1). 75–79. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beverly Metchock Breakdown of academic impact, for papers by Thomas Schön Breakdown of academic impact, for papers by Linda M. Parsons Breakdown of academic impact, for papers by Doris Hillemann Breakdown of academic impact, for papers by Leen Rigouts Breakdown of academic impact, for papers by Sven Hoffner Breakdown of academic impact, for papers by C. Truffot-Pernot Breakdown of academic impact, for papers by Vishwa Mohan Katoch Breakdown of academic impact, for papers by Ákos Somoskövi Breakdown of academic impact, for papers by C N Paramasivan
Rankless by CCL
2026